αV Integrin Induces Multicellular Radioresistance in Human Nasopharyngeal Carcinoma via Activating SAPK/JNK Pathway by Ou, Juanjuan et al.
aV Integrin Induces Multicellular Radioresistance in
Human Nasopharyngeal Carcinoma via Activating SAPK/
JNK Pathway
Juanjuan Ou, Wei Luan, Jia Deng, Rina Sa, Houjie Liang*
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, People’s Republic of China
Abstract
Background: Tumor cells acquire the capacity of resistance to chemotherapy or radiotherapy via cell–matrix and cell–cell
crosstalk. Integrins are the most important cell adhesion molecules, in which aV integrin mainly mediating the tight contact
between tumor cells.
Methodology/Principal Findings: To investigate the role of aV integrin in multi-cellular radioresistance (MCR) of human
nasopharyngealcarcinoma(NPC),weperformedimmunohistochemistryandWesternblottingtofindthattheexpressionofaV
integrin in the tumor tissue of radioresistant patients is much higher than that in radiosensitive patients. In vitro, we cultured
humanNPCcelllineCNE-2cellsasmulti-cellularspheroids(MCSs)orasmonolayercells(MCs),andfoundthattheexpressionof
aV integrin in MCSs is significantly higher than that in MCs. MTT, flow cytometry and clonogenic suvival assays showed that
MCSs are less sensitive to X-ray irradiation than MCs while blocking of aV integrin in MCSs dramatically reversed their
radioresistance. Furthermore, as detected by Western blotting, MCSs displayed sustained activation of the stress-activated
protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) pathway in presence of irradiation. Blocking of aV integrin in MCSs
decreasedtheexpressionofphosphorylatedJNK.Additionally,blockingofSAPK/JNKsignalingpathwaysynergisticallyinduced
apoptosis of MCSs exposed to irradiation by increasing the expression of cleaved caspase-3. In vivo, we found that irradiation
combined with aV integrin blocking treatment significantly enhanced the radiosensitivity of NPC xenografts.
Conclusions: Our results indicate a novel role of aV integrin in multi-cellular radioresistance of NPCs.
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Introduction
Nasopharyngeal carcinoma is the most common malignancy of
head and neck in Southeast Asia, and radiotherapy is the most
effective treatment [1]. Nevertheless, radioresistance still occurs in
a high proportion of NPC patients, which is the main risk factor
contributing to poor prognosis [2]. Thus understanding of the
molecular mechanisms underlying radioresistance may provide
opportunity to develop more effective anti-cancer strategy. The
previous researches about tumor radiosensitivity mainly focus on
a single tumor cell, disregarding the fact that in tumor mass, tumor
cells acquire some new characteristics by interacting with each
other to become more resistant to chemo- or radiotherapy, termed
multi-cellular resistance (MCR) [3].
Integrins are critical cell adhesion molecules mediating the
crosstalk between tumor cells and participating in cell invasion,
metastasis, angiogenesis, cell survival and some other important
biological behaviors of tumor cells [4–8]. More specifically, aV
integrin is expressed in most cancer cells playing an essential role
mediating cell–matrix and cell–cell interactions. Meanwhile, aV
integrin is a key molecule contributing to cell proliferation and
apoptosis [9–11]. Given the correlations between apoptosis and
radiosensitivity, We then hypothesized that aV integrin may act as
a pivotal factor inducing radioresisitance in NPCs.
In this study, we tested the hypothesis that aV integrin may
cause multi-cellular radioresistance of NPC in a three-dimensional
culture condition mimicking a tumor microenvironment, and we
found that aV integrin expression is required for sustaining multi-
cellular radioresistance in human NPC cell line CNE-2. Further-
more, we demonstrated that SAPK/JNK signaling pathway was
involved in aV integrin mediated radioresistance. Our finding for
the first time shows the important role of aV integrin in multi-
cellular radioresistance of nasopharyngeal carcinomas.
Results
aV Integrin is Highly Expressed in NPC Tissues of
Radioresistant Patient, and is Correlated to the
Expressions of Apoptosis Related Genes
To determine whether the expressions of aV integrin of NPC
tumors are different in patients with different radiosensitivity,
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expressions of av integrin in the 105 cases of tumor tissues and 20
cases of adjacent tissues. The positive expressions of av integrin in
NPC tumor tissues were shown to be significantly higher than
those in the adjacent tissues. The expression of av integrin are
correlated to the differentiation degree of cancer cells and lymph
node metastases (p,0.01), but not correlated to the patient’s
gender, age, tumor location or tumor size (p.0.05) (Table 1). We
also found that the expressions of aV integrin in radioresisitant
patients are much higher than those of radiosensitive patients
(Figure 1 A, B) and the levels of av integrin are highly correlated
with the Objective Response Rate (ORR) of NPCs (Table 2).
Given apoptosis is an unarguably common pathway to cell death
initiating from irradiation. We speculate that aV integrin may
affect the levels of apoptotic genes. We therefore measured the
expressions of cleaved Caspase-3 and cleaved PARP in these 105
cases of NPC patients, and found that the expressions of aV
integrin are negatively correlated with the levels of cleaved
Caspase-3 and PARP (P,0.01) (Table 3).
aV Integrin is Differently Expressed in MCSs and MCs
It has been demonstrated in our previous study that aV integrin
is a critical factor mediating MCR to chemotherapy in MCSs [12].
We therefore hypothesized that the expression of aV integrin in
NPC MCSs and MCs may be different. MCSs are cultured as
previously described [12] (Fig. 2 A). As detected by flow cytometry
assay and Western blot. The expression of aV integrin is much
higher in MCSs than that in MCs (Fig. 2 B, C).
Blocking the Function of aV Integrin Reversed
Radioresistance of MCSs
To determine if aV integrin is critical in multi-cellular
radioresistance, we compared the cell survival rate of different
groups with or without aV integrin function blockade in the
presence of irradiation. It showed that blocking the function of aV
integrin dramatically increased the radiosensitivity of MCSs
(Fig. 3A), and more intriguingly, no changes of radiosensitivity
were detected in MCs even after aV integrin blockade (Fig. 3A).
Clonogenic survival assay was also performed to measure the
radiation response. As shown in Figure 3 B, in the presence of
irradiation, blocking the function of aV integrin in MCSs resulted
in a significantly increased radiosensitivity relative to the control
groups, indicating that aV integrin critically contribute to the
radioresistance of MCSs. Meanwhile, aV integrin blocked MCSs
resulted in a substantially decreased cell survival (Fig. 3C) and
increased apoptosis (Fig. 3D) when exposed to 2 Gy fractionated
irradiation. Additionally, the expressions of apoptotic genes
cleaved Caspase-3 and cleaved PARP were found to be increased
significantly in aV integrin blocked MCSs (Fig. 3E).
SAPK/JNK Pathway is Involved in aV Integrin Mediated
Multi-cellular Radioresistance of NPC MCSs
Irradiation is a stress inducing apoptosis in cancer cells, and it is
well known that SAPK/JNK pathway is a critical signaling
activated by stress. To determine the mechanism mediating aV
integrin’s inhibitory function on apoptosis, we investigated the
effect of aV integrin on SAPK/JNK signaling pathways in MCSs.
Western blotting showed that SAPK/JNK was substantially
phosphorylated in MCSs of CNE-2 cells in response to irradiation
(Fig. 4A). Blocking the function of aV integrin in MCSs
substantially decreased the expression of phosphorylated JNK
(Fig. 4B), and blocking of SAPK/JNK pathway increased the
expression of cleaved casepase3 (Fig. 4C). Flow cytometry assay
also showed that irradiation induced apoptosis of MCSs was
increased by blocking SAPK/JNK pathway (Fig. 4D).
aV Integrin Blocking Enhances the Radiosensitivity of
NPC Xenografts
To further confirm the effect of aV integrin on radiosensitivity
of NPCs, we injected equal number (1.0610
6 per mouse) of CNE-
2 cells subcutaneously into nude mice (3 mice for each group). The
mice were exposed to 6 Gy fractionated irradiation, and
a peritumoral injection of aV integrin blocking peptide or isotype
blocking peptide (10 mg/kg, twice a week) were also administrated
when the xenografts reached a mean diameter of 0.8–1.0 cm. The
xenografts were excised and weighed 3 weeks after treatment. As
shown in Fig. 5A and Fig. 5B, aV integrin blockade synergistically
increased the effect of irradiation on xenografts. Xenografts were
then fixed with 2% paraformaldehyde and dissected into sections
at 8 mm. Immunochemistry staining of TUNEL was performed
and found that the apoptosis of tumor in aV integrin blockade
combined group is significantly higher than that in control groups
(Fig. 5C). All of these indicate that aV integrin blockade may
increase radiosensitivity of NPCs.
Discussion
Previously, our group have found that downregulation of aV
integrin promoted drug sensitivity in colorectal carcinoma multi-
cellular spheroids [12]. We therefore propose that loss of aV
integrin function also enhances multi-cellular radiosensitivity. Our
present study shows that aV integrin also contributes to multi-
cellular radioresistance in NPCs by exacerbating irradiation
induced apoptosis. More significantly, the expressions of aV
integrin in human NPC tumors negatively correlate to the levels of
apoptosis related genes, highlighting the potential role of aV
integrin-mediated anti-apoptosis reprogramming in human NPCs.
Table 1. The correlation between aV integrin expression and
clinicopathological features in nasopharyngeal carcinomas.
Variables
No.
patient
aV Integrin
expression P value
2/6 +/++
malignant tissue 105 47 58 0.004
Normal tissue 20 16 4
Age (years) 0.344
#50 41 16 25
.50 64 31 33
Gender 0.743
Male 71 31 40
Female 34 16 18
Location 0.889
Pharynx 23 10 13
Larynx 82 37 45
Differentiation 0.015
well+moderate 72 38 34
poor+nondifferentiated 33 9 24
Nodal status 0.027
Negative 59 32 27
Positive 46 15 31
doi:10.1371/journal.pone.0038737.t001
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integrin acting as a tumor protector by regulating multi-cellular
radioresistance in NPCs.
Our findings are consistent with the previous work showing
that anti- aV integrin can enhance the efficacy of radiation
therapy and reduce metastasis of human cancer xenografts in
nude mice [13,14]. More importantly and intriguingly, in our
study, we present data to demonstrate that blocking the function
of aV integrin in monolayers has little effect on their response to
irradiation, indicating that aV integrin is only crucial for multi-
cellular spheroids or biomass tumor in vivo. Furthermore, our
studies have shed light on the mechanism through which aV
integrin regulating apoptosis. Factors activating aV integrin are
extensive, including intra- and extra-cellular factors, such as
cytoskeleton, fibronectin, virus, force, shear stress, cell–cell
adhesion, and cell-ECM adhesion [15–19]. In MCSs, cells
adhere with each other and cell–cell junctions exist generally,
leading to the hypothesis that aV integrin may be activated by
cell–cell adhesion in MCSs and biomass tumor [20,21]. Other-
wise, cell adhesion might provide a precondition for facilitators to
activate aV integrin. aV integrin has been thought of as a cell
adhesion receptor regulating signal transduction pathways of cell
Figure 1. The expressions of aV integrin in NPC tumor tissues of radioresistant patients and radiosensitive patients. A: The
immunoflurorescence and immunohistochemistry staining of aV integrin in the tumor tissues of NPC patients. (6100). B: The protein expression of
aV integrin of NPC tumors.
doi:10.1371/journal.pone.0038737.g001
Table 2. The correlation between aV integrin and objective
response rate.
ORR Number of patients P value
aV integrin low
expression
aV integrin high
expression
CR 55 6 ,0.001
PR+SD 13 31
RLN 8 29 ,0.01
NRLN 60 8
RRLN: Residual of Cervical Lymph Node; NRRLN: No Residual of Cervical
Lymph Node; ORR: Objective Response Rate; CR: Complete Response;
PR: Partial Response; SD: Stable Disease.
doi:10.1371/journal.pone.0038737.t002
Table 3. Protein expression correlation between Caspase-3,
PARP and aV integrin in NPC tissue samples.
Factor Expression Total Number of patients P value
aV integrin
high
expression
aV integrin low
expression
11 65 ,0.001
Low 29 19 10
PARP High 79 15 54 ,0.001
Low 26 20 6
doi:10.1371/journal.pone.0038737.t003
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liferation, survival, and apoptosis are three of the most critical
factors impacting radiosensitivity. [24–26]. This may be in part
of the mechanism of activation of aV integrin in MCR.
Apoptosis is an unarguably common pathway to cell death
initiating from irradiation [27], and NF-kB and JNK2 are two of
the most important apoptotic factors, especially underlying stress
[28]. It has already been demonstrated that aV integrin can
activate NF-kB and inactivate JNK in some kinds of cells [29].
As a result in our study, we found that blocking SAPK/JNK
pathway reversed radioresistance in MCSs, indicating that
SAPK/JNK pathway is critical mediating MCR. It has been
reported that SAPK/JNK pathway can be dramatically activated
by endoplasmic reticulum stress (ER stress) [30,31] and
endoplasmic reticulum is well known to be the compartment of
protein synthesis, including apoptotic related proteins. This
correlation may explain how aV integrin blocking results in an
increased expression of caspase 3 and PARP. Although we can
not draw a conclusion that SAPK/JNK pathway is the only
pathway triggered by aV integrin mediated multicellular radio-
resisitance, the evidence we got has given us a hint that SAPK/
JNK pathway can be directly or indirectly activated by aV
integrin. Our studies have revealed the profound impact of aV
integrin on MCR to radiosensitivity, and it will be important for
future work to examine the effect of aV integrin on each stage of
NPC tumorigenesis in mechanistic detail.
The combination of molecular-targeted agents with irradiation
is a highly promising avenue for cancer research and patient care.
Given the role of aV integrin in mediating NPC radioresistance,
aV integrin should be a potential target to improve the efficiency
of radiosensitivity in NPCs.
Materials and Methods
Samples Collection
A tissue chip consisting of 105 human nasopharyngeal
carcinoma (NPC) specimens was purchased from Shanghai
Outdo Biotech Co.,Itd. A separated set of tissue specimens used
for immunohistochemistry and Western blotting studies were
collected from NPC patients who had undergone biopsies at
Southwest Hospital under a protocol approved by Southwest
Hospital. The Objective Response Rate (ORR) and
histological subtypes were defined by an oncologist (pathologist)
in the Southwest Cancer Center, Southwest Hospital. Com-
plete Response (CR) means all detectable tumor has
disappeared; Partial Response (PR) corresponds to at least
a 50% decrease in the total tumor volume but with evidence of
some residual disease still remaining; Stable Disease (SD)
means the tumors stay the same size, to account for
Figure 2. aV integrin levels in MCs and MCSs. A: Morphology of MCs and MCSs. B: The expressions of aV integrin in MCs and MCSs. C: The
expressions of aV integrin in MCs and MCSs detected by Flow Cytometry. Values are means 6 SEM, *P,0.01.
doi:10.1371/journal.pone.0038737.g002
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e38737Figure 3. The effect of aV integrin on radiosensitivity of NPC cells in vitro. A: Cell survival of MCs and MCSs in presence of different dose of
irradiation (0–8 Gy) combined with or without aV integrin blockade. Data are compared by one-way ANOVA Statistical, *p,0.01. B: Colony survival
curves of MCSs in the presence of different dose of radiation (0–8 Gy) combined with or without aV integrin treatment respectively, *p,0.01.
C: Images and quantification of the number and size of colonies formed from MCSs treated with or without aV integrin treatment in the presence of
2 Gy irradiation, *p,0.01. D: The Annexin-V assay of apoptosis for MCSs treated with or without aV integrin treatment in presence of irradiation,
*p,0.01. Data are expressed by the percentage of cells that were stained with Annexin. E: The protein levels of cleaved caspase 3 in MCSs treated
with or without aV integrin treatment in the presence of irradiation.
doi:10.1371/journal.pone.0038737.g003
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changes, stable disease includes either a small amount of growth
(typically less than 20 or 25%) or a small amount of shrinkage
(anything less than a PR unless minor responses are broken
out). Radiosensitive patients are clarified as those reached CR 2
to 4 weeks after irradiation therapy (GTV.70 Gy), and
radioresistant patients are clarified as those of PR or SD or
even with disease progression 2 to 4 weeks after irradiation
therapy (GTV.70 Gy).
Assessment of Immunohistochemical Staining
Immunohistochemical staining was scored as 0–4. No staining
or weak staining were scored was 0 and 1, respectively. Strong
staining of 25% tumor cells or moderate staining of ,80%
scored 2. Strong staining of 25–50% or moderate staining of
.80%, and strong staining of .50% tumor cells, scored 3 and 4,
respectively. Ten representative areas were counted in each case
from high power fields. Slides were examined and scored
independently by 2 researchers blinded to other pathological
information.
Cell Culture
CNE-2 cells were routinely grown and passaged as monolayers
in RPMI1640 medium (HyClone, UK) supplemented with 5%
fetal bovine serum, penicillin (100 IU/mL), and streptomycin
(100 mg/mL) under a humidified atmosphere of 5% CO2 at 37uC.
MCSs were obtained by using the liquid overlay technique.
Exponentially-growing CNE-2 cells were added in culture medium
in plates which were previously coated with 2% agarose. The
plates were gently horizontally swirled 10 min every 3 h in the first
24 h, then 10 min every 4 h. Appropriate medium was refreshed
every other day. For antibody treatment, cells were incubated with
purified endotoxin-free mAbs (175 mg/ml) for 24 h.
Western Blotting
Cells were washed with phosphate-buffered saline (PBS) and
lysed at 4uC. in 26SDS loading buffer (0.1 M Tris–HCl [pH 6.8],
0.2 M DTT, 4% SDS, 20% glycerol, and 0.2% bromophenol
blue). Protein was quantitated by using the RC DC protein assay
(BIO-RAD, CA, USA), resolved by 8% SDS–PAGE, and
transferred to nitrocellulose membranes (Qbiogene, UK). Target
protein was detected by anti-aV integrin (Santa Cruz Bio-
technology, Santa Cruz CA, USA), anti-SAPK/JNK antibody
(Cell Signaling Technology), anti-phospho-SAPK/JNK antibody
(Cell Signaling Technology), anti-cleaved caspase-3 (Santa cruz),
goat polyclonal antibody against cleaved caspase-9 (Santa cruz)
and rabbit polyclonal antibody against cleaved poly ADP-ribose
polymerase (PARP) (Santa cruz). After washing and incubating
with secondary antibodies, immunoreactive proteins were visual-
ized by the Enhanced Chemiluminescnet Substrate (Pierce, IL,
USA).
Cell Survival Assay
Cell survival was evaluated by using the cell counting kit 8
(Dojindo Laboratories, Japan). In contrast to monolayers, MCSs
were digested by Non-enzyme Cell Detach Solution (Applygen
Technologies, China) for 10 min before using the cell counting kit
8 to detect cell survival.
Figure 4. Molecular response of aV integrin mediate radioresistance in MCSs. A: Time-course level of phosphorylated JNK in presence of
irradiation. B: The level of phosphorylated JNK 2 hrs after irradiation. C: The level of cleaved caspase 3 in MCSs treated with or without SAPK/JNK
pathway inhibitor SP-600125. D: Apoptosis in MCSs treated with or without SAPK/JNK pathway inhibitor SP-600125.
doi:10.1371/journal.pone.0038737.g004
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Cells were seeded into 24-well culture dishes in triplicates
(1000 cells to each well). The cells were allowed to form colonies
during 1 week, and then cells were treated with different doses of
6MV X-ray radiation [IBL 637; Cis-Bio International, Gif-sur-
Yvette, France]. The radiation doses were 0, 2, 4, 6 and 8 Gy,
respectively; the dose efficiency was 300 cGy/min. After an
incubation period of 12–15 days, the colonies were fixed with
methanol and stained with crystal violet. Colonies of .50 cells
were counted and analyzed.
Flow Cytometry Analysis of Apoptosis
Flow cytometry was performed to detect apoptosis of trypsin-
dissociated cells with AnnixinV-PE apoptosis Detection Kit
(Beyotime). Cells were washed and resuspended in 0.5 ml PBS
buffer, and fixed for 24 hr in 70% alcohol. Annixin V- PE (50 mg/
ml) was added and incubated for 30 min on ice, and then analyzed
by FCM (FACScan, Becton Dickinson, San Jose, CA).
In vivo Study
Female BALB/c (nu/nu) nude mice, 4–5 weeks old, weighing
17–22 g, were housed in filter-capped cages kept in a sterile facility
and maintained in a specific pathogen-free barrier system. After 3
weeks, xenografts established by subcutaneous injection CNE-2
MCSs in mouse hips reached a mean diameter of 0.8–1.0 cm, and
then 6 Gy fractionated irradiation combined with or without daily
peritumoral injection of aV integrin blocking peptide or isotype
blocking peptide (Santa Cruz Biotechnology, Santa Cruz CA,
USA) were administrated (10 mg/Kg, twice a week). Mice were
sacrificed 3 weeks later and the xenografts were excised and
weighed.
Statistical Analysis
Statistical analysis was performed with SPSS (SPSS, Chicago,
IL) using Students t-test or one-way ANOVA. Differences were
considered statistically significant when P-values were less than
0.05. Error bars represent standard error of the mean.
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Figure 5. Effect of aV integrin blocking on radioresponse of NPC xenografts in mice with irradiation treatment. Same volume of MCSs
(100 ml per mouse) were injected subcutaneously, Mice were treated with local radiation at a fractionated dose of 6 Gy combined with aV integrin
blocking peptide or isotype blocking peptide peritumoral treatment (10 mg/Kg, twice a week) when the xenografts reached a mean size of 0.8–1 cm.
Tumor weight was measured when the mice were sacrificed after 3 weeks. Each data point represents the mean weight of 3 tumors; A: Xenograft
weight was measured when the mice were sacrificed 3 weeks after radiotherapy. A photograph of a representative xenograft in each group is also
shown, *P,0.01. B: The decrease of xenograft size was measured every 2 days after radiotherapy, *p,0.01. C: Apoptosis detected by TUNEL assay
was shown to compare the effect of aV integrin blocking peptide on radiosensitivity of in irradiated xenografts (6100).
doi:10.1371/journal.pone.0038737.g005
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